Status:
UNKNOWN
The Use of Prostaglandin E1 in Head and Neck Microsurgery
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Microsurgery
Head and Neck
Eligibility:
All Genders
20-80 years
Phase:
PHASE4
Brief Summary
Prostaglandin E1 (PGE1 )has been shown to have vasodilatation and anti-thrombosis effects, so it is used by some surgeons after microsurgery to keep the patency of the anastomosed small vessels. Howev...
Detailed Description
Despite meticulous microsurgical techniques, free flap failure due to postoperative vessel thrombosis cannot be completely eliminated. Postoperative pharmacological augmentation of the established blo...
Eligibility Criteria
Inclusion
- Patients requiring microvascular reconstruction after head and neck cancer resection
Exclusion
- Patients with coagulation dysfunction
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2010
Estimated Enrollment :
242 Patients enrolled
Trial Details
Trial ID
NCT00733434
Start Date
July 1 2008
End Date
July 1 2010
Last Update
October 27 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National taiwan University Hospital
Taipei, Taiwan, 100